Back
Hepion Pharmaceuticals Stock Price Chart
Sponsored
HEPA
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
HEPA
Hepion Pharmaceuticals
Last Price:
0.68
Seasonality Move:
-5.28%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HEPA is experiencing slight buying pressure.
Hepion Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.7 | Sell |
20-day SMA: | 0.75 | Sell |
50-day SMA: | 0.77 | Sell |
200-day SMA: | 1.72 | Sell |
8-day EMA: | 0.7 | Sell |
20-day EMA: | 0.73 | Sell |
50-day EMA: | 0.81 | Sell |
200-day EMA: | 2.21 | Sell |
Hepion Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 42.16 | Sell |
Chaikin Money Flow: | 5450 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.69 - 0.79) | Sell |
Bollinger Bands (100): | (0.73 - 1.21) | Sell |
Hepion Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Hepion Pharmaceuticals Stock
Is Hepion Pharmaceuticals Stock a Buy?
- Hepion Pharmaceuticals share price is 0.68 while HEPA 8-day simple moving average is 0.70, which is a Sell signal.
- The stock price of HEPA is 0.68 while Hepion Pharmaceuticals 20-day SMA is 0.75, which makes it a Sell.
- Hepion Pharmaceuticals 50-day simple moving average is 0.77 while HEPA share price is 0.68, making it a Sell technically.
- HEPA stock price is 0.68 and Hepion Pharmaceuticals 200-day simple moving average is 1.72, creating a Sell signal.
HEPA Technical Analysis vs Fundamental Analysis
Sell
25
Hepion Pharmaceuticals (HEPA)
is a Sell
Is Hepion Pharmaceuticals a Buy or a Sell?
-
Hepion Pharmaceuticals stock is rated a Sell
The current Hepion Pharmaceuticals [HEPA] share price is $0.68. The Score for HEPA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Hepion Pharmaceuticals Stock Info
Market Cap:
3.93M
Price in USD:
0.68
Share Volume:
18.23K
Hepion Pharmaceuticals 52-Week Range
52-Week High:
5.77
52-Week Low:
0.55
Sell
25
Hepion Pharmaceuticals (HEPA)
is a Sell
Hepion Pharmaceuticals Share Price Forecast
-
What is the Hepion Pharmaceuticals stock price today?
The Hepion Pharmaceuticals stock price is 0.68 USD today. -
Will HEPA stock go up or go down?
Hepion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Hepion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Hepion Pharmaceuticals is overvalued.
Is Hepion Pharmaceuticals Stock a Buy?
- Hepion Pharmaceuticals share price is 0.68 while HEPA 8-day exponential moving average is 0.70, which is a Sell signal.
- The stock price of HEPA is 0.68 while Hepion Pharmaceuticals 20-day EMA is 0.73, which makes it a Sell.
- Hepion Pharmaceuticals 50-day exponential moving average is 0.81 while HEPA share price is 0.68, making it a Sell technically.
- HEPA stock price is 0.68 and Hepion Pharmaceuticals 200-day simple moving average is 2.21, creating a Sell signal.
Fundamental Analysis of Hepion Pharmaceuticals
Is Hepion Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $1.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Hepion Pharmaceuticals
Should I short Hepion Pharmaceuticals stock?
- HEPA Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Hepion Pharmaceuticals is a Sell
- Hepion Pharmaceuticals Relative Strength Index (RSI) is 42.16, which suggest Hepion Pharmaceuticals is oversold
- The Bollinger Bands (25) for Hepion Pharmaceuticals is (0.69 - 0.79), which suggest Hepion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Hepion Pharmaceuticals is (0.73 - 1.21), which suggest Hepion Pharmaceuticals is a Sell
* Hepion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.